Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ono Pharmaceutical Co. (OPHLF : OTC)

• Company Description    Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals. Number of Employees: 3,853

• Price / Volume Information    Yesterday's Closing Price: $10.79 Daily Weekly Monthly 20 Day Moving Average: 140 shares Shares Outstanding: 469.71 (millions) Market Capitalization: $5,068.15 (millions) Beta: 0.49 52 Week High: $16.05 52 Week Low: $9.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.75% -3.03% 12 Week -8.64% -23.15% Year To Date 12.40% 5.26%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8-2 Kyutaromachi 1-chome Chuo-ku - Osaka,M0 541-8564 JPN ph: 816-6263-5670 fax: 816-6263-2950 None http://www.ono-pharma.com

• General Corporate Information    Officers GyoSagara - Chief Executive Officer and President Toshihiro Tsujinaka - Director Toichi Takino - Director Kiyoaki Idemitsu - Director Masao Nomura - Director Peer Information Ono Pharmaceutical Co. (GSAC) Ono Pharmaceutical Co. (CASI) Ono Pharmaceutical Co. (ALCD.) Ono Pharmaceutical Co. (OMNN) Ono Pharmaceutical Co. (CGPI.) Ono Pharmaceutical Co. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: J61546115 SIC: 2834 Fiscal Year Fiscal Year End: March Last Reported Quarter: 03/01/25 Next Expected EPS Date: 07/30/25 Share - Related Items Shares Outstanding: 469.71 Most Recent Split Date: 3.00 (5.00:1) Beta: 0.49 Market Capitalization: $5,068.15 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/30/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 15.41 PEG Ratio: - Price Ratios Price/Book: 0.97 Price/Cash Flow: 10.01 Price / Sales: 1.59 EPS Growth vs. Year Ago Period: -136.00% vs. Previous Quarter: -142.86% Sales Growth vs. Year Ago Period: -3.00% vs. Previous Quarter: -16.40% ROE 06/30/25 - - 03/31/25 - 6.20 12/31/24 - 9.10 ROA 06/30/25 - - 03/31/25 - 4.66 12/31/24 - 7.12 Current Ratio 06/30/25 - - 03/31/25 - 3.07 12/31/24 - 3.55 Quick Ratio 06/30/25 - - 03/31/25 - 2.56 12/31/24 - 2.91 Operating Margin 06/30/25 - - 03/31/25 - 10.24 12/31/24 - 15.15 Net Margin 06/30/25 - - 03/31/25 - 10.24 12/31/24 - 15.15 Pre-Tax Margin 06/30/25 - - 03/31/25 - 12.19 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 11.07 12/31/24 - 11.54 Inventory Turnover 06/30/25 - - 03/31/25 - 2.30 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.13 12/31/24 - 0.14 Debt-to-Capital 06/30/25 - - 03/31/25 - 11.76 12/31/24 - 12.05

Powered by Zacks Investment Research ©